We analyzed tumor mutation burden in the high-risk and low-risk groups, identifying tumor protein P53 (TP53), titin (TTN), and mucin 16 (MUC16) as the top mutated genes and missense variations constituting the predominant mutation type (Fig. S7A, B). The gene discussed is TTN; the disease is neoplasm.